Mazzarotto, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 406
AS - Asia 375
EU - Europa 237
AF - Africa 7
SA - Sud America 4
OC - Oceania 3
Totale 1.032
Nazione #
US - Stati Uniti d'America 401
SG - Singapore 168
HK - Hong Kong 133
TR - Turchia 48
IE - Irlanda 44
IT - Italia 42
RU - Federazione Russa 37
DE - Germania 35
GB - Regno Unito 30
FI - Finlandia 21
CN - Cina 13
AT - Austria 9
CA - Canada 5
IN - India 4
SE - Svezia 4
AU - Australia 3
BR - Brasile 3
CH - Svizzera 3
FR - Francia 3
MA - Marocco 3
BE - Belgio 2
CZ - Repubblica Ceca 2
IR - Iran 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
KH - Cambogia 1
KR - Corea 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.032
Città #
Hong Kong 133
Singapore 106
Princeton 82
Fairfield 50
Istanbul 45
Dublin 42
San Diego 22
Helsinki 21
Houston 19
Seattle 19
Wilmington 19
Moscow 17
Villa Carcina 14
Des Moines 13
Ann Arbor 12
Woodbridge 12
Ashburn 11
Cambridge 10
London 9
Nuremberg 9
Pontassieve 9
Brescia 8
San Francisco 8
Los Angeles 6
Romola 5
Tianjin 5
Toronto 5
Vienna 5
Kilburn 4
Sheffield 4
Chiswick 3
Hanover 3
Melbourne 3
New York 3
Zurich 3
Atlanta 2
Bremen 2
Brussels 2
Everett 2
Frankfurt am Main 2
Salò 2
São Paulo 2
Wandsworth 2
Acton 1
Baku 1
Bangkok 1
Beijing 1
Brno 1
Cascina 1
Chengdu 1
Chuncheon 1
Copenhagen 1
Gunzenhausen 1
Ho Chi Minh City 1
Hyderabad 1
Laguna Niguel 1
Manassas 1
Oklahoma City 1
Oslo 1
Ouagadougou 1
Pedro Leopoldo 1
Phnom Penh 1
Prague 1
Prescot 1
Pune 1
Rabat 1
Redmond 1
Shanghai 1
Southwark 1
Stockholm 1
Suleja 1
Tallinn 1
Tower Hamlets 1
Totale 785
Nome #
Genome-wide association testing beyond SNPs 60
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy 32
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies 32
FineSplice, enhanced splice junction detection and quantification: a novel pipeline based on the assessment of diverse RNA-Seq alignment solutions 30
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy 28
ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure 28
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy 28
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? 27
Comprehensive Assessment of Rare Genetic Variation in Dilated Cardiomyopathy Genes in Patients and Controls (vol 101, pg A41, 2015) 26
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients with Hypertrophic Cardiomyopathy 26
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease 26
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 25
Quantifying evidence toward pathogenicity for rare phenotypes: the case of succinate dehydrogenase genes, SDHB and SDHD 25
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 24
Two decades of genetic testing in hypertrophic cardiomyopathy in a single center: The additive value of extended next-generation sequencing panels lies in the early diagnosis of metabolic mimics 23
EFFECTS OF TRUNCATING VARIANTS IN TITIN ON CARDIAC PHENOTYPE AND LEFT VENTRICULAR REMODELLING IN DILATED CARDIOMYOPATHY 23
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 23
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 23
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 23
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 22
CLINICAL AND GENETIC CHARACTERISTICS OF FAMILIAL DILATED CARDIOMYOPATHY IN A LARGE UK PROSPECTIVE COHORT 22
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples 22
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation 22
Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions 22
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy 22
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect 22
INTEGRATED ALLELIC, TRANSCRIPTIONAL, AND PHENOTYPIC DISSECTION OF THE CARDIAC EFFECTS OF TITIN VARIATION IN HEALTH AND DISEASE 22
Temporal trend in age at diagnosis of hypertrophic cardiomyopathy: an analysis of the share registry 21
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death 21
Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning 21
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 20
Temporal Trend in Age at Diagnosis of Hypertrophic Cardiomyopathy: An Analysis of the Share Registry 20
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 20
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies 19
RE-EVALUATING THE GENETIC CONTRIBUTION OF MONOGENIC DILATED CARDIOMYOPATHY 19
Comprehensive sequencing of dilated cardiomyopathy genes reveals additive effects of multiple genes on disease risk and severity 19
Titin-truncating variants affect heart function in disease cohorts and the general population 19
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death 19
Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy 18
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases 17
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 17
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 16
Genetic ancestry analysis of the Italian founder population carrying the cardiac amyloidosis-causing variant Val122Ile in the transthyretin gene 16
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy 16
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy 16
Ion channel dysfunction and fubrosis in atrial fibrillation:Two sides of the same coin 15
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy 14
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 12
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 9
Totale 1.092
Categoria #
all - tutte 18.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 127 16 2 6 0 18 46 8 13 2 13 79
2022/2023107 41 0 1 4 1 42 2 0 6 9 1 0
2023/2024201 1 2 15 15 5 5 5 4 99 2 0 48
2024/2025454 1 6 6 85 88 49 71 84 64 0 0 0
Totale 1.092